{"id":62748,"date":"2026-03-06T04:06:42","date_gmt":"2026-03-06T03:06:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/humana-prices-1-0-billion-fixed-to-fixed-rate-junior-subordinated-notes-offering\/"},"modified":"2026-03-06T04:06:42","modified_gmt":"2026-03-06T03:06:42","slug":"humana-prices-1-0-billion-fixed-to-fixed-rate-junior-subordinated-notes-offering","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/humana-prices-1-0-billion-fixed-to-fixed-rate-junior-subordinated-notes-offering\/","title":{"rendered":"Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering"},"content":{"rendered":"
\n

LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (the \u201ccompany\u201d) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the \u201cJunior Subordinated Notes Offering\u201d). The Junior Subordinated Notes Offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters\u2019 discounts and estimated offering expenses. The company intends to use the net proceeds from the Junior Subordinated Notes Offering for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under its commercial paper program.<\/p>\n

\nGoldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC are acting as active joint book-running managers for the Junior Subordinated Notes Offering.<\/p>\n

\nThe Junior Subordinated Notes Offering is being made pursuant to an effective shelf registration statement (including a base prospectus) filed with the Securities and Exchange Commission (the \u201cSEC\u201d). The Junior Subordinated Notes Offering may be made only by means of a prospectus and related prospectus supplement, copies of which may be obtained by contacting Goldman Sachs & Co. LLC toll-free at +1-866-471-2526; J.P. Morgan Securities LLC by email at prospectus-eq_fi@jpmchase.com<\/a> or postsalemanualrequests@broadridge.com<\/a>; Mizuho Securities USA LLC toll-free at +1-866-271-7403; Truist Securities, Inc toll-free at +1-800-685-4786; or Wells Fargo Securities, LLC toll-free at +1-800-645-3751. An electronic copy of the registration statement and prospectus supplement, together with the base prospectus, is available on the SEC\u2019s website at www.sec.gov<\/a>.<\/p>\n

\nThis news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.<\/p>\n

\nCautionary Statement<\/span><\/b><\/p>\n

\nThis news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, SEC filings, and in oral statements made by or with the approval of one of Humana\u2019s executive officers, the words or phrases like \u201cexpects,\u201d \u201cbelieves,\u201d \u201canticipates,\u201d \u201cassumes,\u201d \u201cintends,\u201d \u201clikely will result,\u201d \u201cestimates,\u201d \u201cprojects\u201d or variations of such words and similar expressions are intended to identify such forward-looking statements.<\/p>\n

\nThese forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the \u201cRisk Factors\u201d section of the company\u2019s SEC filings, a summary of which includes but is not limited to the following:<\/p>\n